IS4731A - Kínólín og kínazólín efnasambönd nytsamleg í meðferð - Google Patents

Kínólín og kínazólín efnasambönd nytsamleg í meðferð

Info

Publication number: IS4731A
Authority: IS; Iceland
Prior art keywords: quinoline; treatment; compounds useful; quinazoline compounds; quinazoline
Prior art date: 1995-12-23

Application number

IS4731A

Other languages

English (en)

Inventor

John Collis Alan

Nathan Abraham Fox David

Newman Julie

Original Assignee

Pfizer Research And Development Company, N.V./S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-23

Filing date

1998-04-29

Publication date

1998-04-29

1998-04-29 Application filed by Pfizer Research And Development Company, N.V./S.A. filed Critical Pfizer Research And Development Company, N.V./S.A.

1998-04-29 Publication of IS4731A publication Critical patent/IS4731A/is

Links

SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 2
125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Quinoline Compounds (AREA)

IS4731A 1995-12-23 1998-04-29 Kínólín og kínazólín efnasambönd nytsamleg í meðferð IS4731A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9526546.8A GB9526546D0 (en)	1995-12-23	1995-12-23	Compounds useful in therapy
PCT/EP1996/005609 WO1997023462A1 (en)	1995-12-23	1996-12-05	Quinoline and quinazoline compounds useful in therapy

Publications (1)

Publication Number	Publication Date
IS4731A true IS4731A (is)	1998-04-29

Family

ID=10786091

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS4731A IS4731A (is)	1995-12-23	1998-04-29	Kínólín og kínazólín efnasambönd nytsamleg í meðferð

Country Status (34)

Country	Link
US (3)	US6103738A (is)
EP (1)	EP0877734B1 (is)
JP (1)	JP3070958B2 (is)
KR (1)	KR19990076693A (is)
AP (1)	AP715A (is)
AR (1)	AR005166A1 (is)
AT (1)	ATE194598T1 (is)
AU (1)	AU708979B2 (is)
BG (1)	BG102559A (is)
BR (1)	BR9612263A (is)
CA (1)	CA2236814C (is)
CO (1)	CO4480106A1 (is)
CZ (1)	CZ197698A3 (is)
DE (1)	DE69609353T2 (is)
DK (1)	DK0877734T3 (is)
ES (1)	ES2151192T3 (is)
GB (1)	GB9526546D0 (is)
GR (1)	GR3034225T3 (is)
HN (1)	HN1996000082A (is)
HR (1)	HRP960616A2 (is)
HU (1)	HUP9903560A3 (is)
IS (1)	IS4731A (is)
MA (1)	MA26414A1 (is)
NO (1)	NO982913L (is)
NZ (1)	NZ325248A (is)
OA (1)	OA10703A (is)
PL (1)	PL327610A1 (is)
PT (1)	PT877734E (is)
SK (1)	SK81698A3 (is)
TN (1)	TNSN96161A1 (is)
TR (1)	TR199801195T2 (is)
WO (1)	WO1997023462A1 (is)
YU (1)	YU68896A (is)
ZA (1)	ZA9610784B (is)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ325248A (en) *	1995-12-23	1999-09-29	Pfizer Res & Dev	Quinoline and quinazoline compounds useful in therapy
GB9700504D0 (en)	1997-01-11	1997-02-26	Pfizer Ltd	Pharmaceutical compounds
GB9708917D0 (en) *	1997-05-01	1997-06-25	Pfizer Ltd	Compounds useful in therapy
GB9711220D0 (en) *	1997-05-30	1997-07-23	Isis Innovation	Antiarrhythmic agents
GB9711650D0 (en) *	1997-06-05	1997-07-30	Pfizer Ltd	Compounds useful in therapy
EP1315714B1 (en) *	2000-08-31	2005-11-09	F. Hoffmann-La Roche Ag	Quinazoline derivatives as alpha-1 adrenergic antagonists
US6900220B2 (en)	2001-01-02	2005-05-31	Syntex (U.S.A.) Llc	Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
WO2002053558A1 (en) *	2001-01-02	2002-07-11	F.Hoffman-La Roche Ag	Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
US6734303B2 (en)	2001-05-18	2004-05-11	Pfizer Inc.	Process for the production of quinazolines
GB0206033D0 (en)	2002-03-14	2002-04-24	Pfizer Ltd	Compounds useful in therapy
US7576074B2 (en)	2002-07-15	2009-08-18	Rice Kenneth D	Receptor-type kinase modulators and methods of use
EP1556381B1 (en)	2002-09-26	2008-02-20	Pfizer Limited	Pyrazole amides for treating hiv infections
CA2523431A1 (en)	2003-04-23	2004-11-25	Glaxo Group Limited	Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
WO2005030131A2 (en) *	2003-09-23	2005-04-07	Replidyne, Inc	Bis-quinazoline compounds for the treatment of bacterial infections
EP2210607B1 (en)	2003-09-26	2011-08-17	Exelixis Inc.	N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer
LT2502911T (lt)	2004-06-24	2017-09-11	Vertex Pharmaceuticals Incorporated	Atp surišančios kasetės transporterių moduliatoriai
WO2007079139A2 (en)	2005-12-28	2007-07-12	Vertex Pharmaceuticals, Inc.	Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US9114194B2 (en) *	2006-05-12	2015-08-25	W. L. Gore & Associates, Inc.	Immobilized biologically active entities having high biological activity following mechanical manipulation
US8986713B2 (en) *	2006-05-12	2015-03-24	W. L. Gore & Associates, Inc.	Medical device capable of being compacted and expanded having anti-thrombin III binding activity
US20080279909A1 (en) *	2006-05-12	2008-11-13	Cleek Robert L	Immobilized Biologically Active Entities Having A High Degree of Biological Activity Following Sterilization
US8496953B2 (en) *	2006-05-12	2013-07-30	W. L. Gore & Associates, Inc.	Immobilized biologically active entities having a high degree of biological activity following sterilization
US8021677B2 (en)	2006-05-12	2011-09-20	Gore Enterprise Holdings, Inc.	Immobilized biologically active entities having a high degree of biological activity
SG179418A1 (en) *	2007-03-14	2012-04-27	Exelixis Patent Co Llc	Inhibitors of the hedgehog pathway
US20100074949A1 (en)	2008-08-13	2010-03-25	William Rowe	Pharmaceutical composition and administration thereof
US12458635B2 (en)	2008-08-13	2025-11-04	Vertex Pharmaceuticals Incorporated	Pharmaceutical composition and administrations thereof
KR101337163B1 (ko)	2008-11-14	2013-12-05	에프. 호프만-라 로슈 아게	Ｎｋ3 수용체 길항제로서 퀴나졸린 유도체
NZ779754A (en)	2009-01-16	2023-04-28	Exelixis Inc	Malate salt of n-(4-{ [6,7-bis(methyloxy)quinolin-4-yl] oxy} phenyl)-n’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
SI2408750T1 (sl)	2009-03-20	2015-11-30	Vertex Pharmaceuticals Incorporated	Postopek za izdelavo modulatorjev cistično-fibroznega transmembranskega regulatorja prevodnosti
AU2010227311B2 (en) *	2009-03-23	2014-06-05	Cipla Limited	Process for the preparation of doxazosin and salts thereof
UA108618C2 (uk)	2009-08-07	2015-05-25		Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
EA021113B1 (ru) *	2009-09-03	2015-04-30	Бристол-Майерс Сквибб Кампани	Хиназолины в качестве ингибиторов калиевых каналов
US8591932B2 (en) *	2009-09-17	2013-11-26	W. L. Gore & Associates, Inc.	Heparin entities and methods of use
ES2955183T3 (es)	2011-03-11	2023-11-29	Gore & Ass	Mejoras para las entidades biológicas inmovilizadas
WO2013043255A1 (en) *	2011-09-21	2013-03-28	University Of South Alabama	Methods and compositions for the treatment of ovarian cancer
EP2819670A1 (en)	2012-02-27	2015-01-07	Vertex Pharmaceuticals Incorporated	Pharmaceutical composition and administration thereof
SG11201607973XA (en) *	2014-03-24	2016-11-29	Guangdong Zhongsheng Pharmaceutical Co Ltd	Quinoline derivatives as smo inhibitors
KR20170063954A (ko)	2014-10-07	2017-06-08	버텍스 파마슈티칼스 인코포레이티드	낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정
SG11201811491YA (en)	2016-06-27	2019-01-30	Achillion Pharmaceuticals Inc	Quinazoline and indole compounds to treat medical disorders
MX2021008661A (es)	2019-01-18	2021-08-19	Astrazeneca Ab	Inhibidores de la pcsk9 y metodos de uso de los mismos.
BR112021013807A2 (pt) *	2019-01-18	2021-11-30	Astrazeneca Ab	Inibidores de pcsk9 e seus métodos de uso

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR79603B (is) *	1982-07-24	1984-10-31	Pfizer
GB8506174D0 (en) *	1985-03-09	1985-04-11	Pfizer Ltd	4-amino-6 7-dimethoxy-2-piperazin-1-ylquinazoline derivatives
GB8814458D0 (en) *	1988-06-17	1988-07-20	Wyeth John & Brother Ltd	Heterocyclic compounds
NZ325248A (en) *	1995-12-23	1999-09-29	Pfizer Res & Dev	Quinoline and quinazoline compounds useful in therapy

1995
- 1995-12-23 NZ NZ325248A patent/NZ325248A/en unknown
- 1995-12-23 GB GBGB9526546.8A patent/GB9526546D0/en active Pending
1996
- 1996-12-05 PL PL96327610A patent/PL327610A1/xx unknown
- 1996-12-05 PT PT96943954T patent/PT877734E/pt unknown
- 1996-12-05 ES ES96943954T patent/ES2151192T3/es not_active Expired - Lifetime
- 1996-12-05 BR BR9612263A patent/BR9612263A/pt not_active Application Discontinuation
- 1996-12-05 TR TR1998/01195T patent/TR199801195T2/xx unknown
- 1996-12-05 JP JP9523272A patent/JP3070958B2/ja not_active Expired - Fee Related
- 1996-12-05 EP EP96943954A patent/EP0877734B1/en not_active Expired - Lifetime
- 1996-12-05 WO PCT/EP1996/005609 patent/WO1997023462A1/en not_active Ceased
- 1996-12-05 DE DE69609353T patent/DE69609353T2/de not_active Expired - Fee Related
- 1996-12-05 AT AT96943954T patent/ATE194598T1/de not_active IP Right Cessation
- 1996-12-05 DK DK96943954T patent/DK0877734T3/da active
- 1996-12-05 KR KR1019980704806A patent/KR19990076693A/ko not_active Ceased
- 1996-12-05 CA CA002236814A patent/CA2236814C/en not_active Expired - Fee Related
- 1996-12-05 CZ CZ981976A patent/CZ197698A3/cs unknown
- 1996-12-05 US US09/091,370 patent/US6103738A/en not_active Expired - Fee Related
- 1996-12-05 AU AU13719/97A patent/AU708979B2/en not_active Ceased
- 1996-12-05 HU HU9903560A patent/HUP9903560A3/hu unknown
- 1996-12-05 SK SK816-98A patent/SK81698A3/sk unknown
- 1996-12-12 HN HN1996000082A patent/HN1996000082A/es unknown
- 1996-12-18 MA MA24433A patent/MA26414A1/fr unknown
- 1996-12-18 TN TNTNSN96161A patent/TNSN96161A1/fr unknown
- 1996-12-19 AP APAP/P/1996/000900A patent/AP715A/en active
- 1996-12-20 AR ARP960105804A patent/AR005166A1/es unknown
- 1996-12-20 YU YU68896A patent/YU68896A/sh unknown
- 1996-12-20 ZA ZA9610784A patent/ZA9610784B/xx unknown
- 1996-12-20 CO CO96066994A patent/CO4480106A1/es unknown
- 1996-12-23 HR HR9526546.8A patent/HRP960616A2/xx not_active Application Discontinuation
1998
- 1998-04-29 IS IS4731A patent/IS4731A/is unknown
- 1998-06-18 BG BG102559A patent/BG102559A/xx unknown
- 1998-06-22 NO NO982913A patent/NO982913L/no not_active Application Discontinuation
- 1998-06-23 OA OA9800092A patent/OA10703A/en unknown
2000
- 2000-08-17 GR GR20000401910T patent/GR3034225T3/el not_active IP Right Cessation
2001
- 2001-03-19 US US09/812,083 patent/US6642242B2/en not_active Expired - Fee Related
2003
- 2003-06-04 US US10/455,546 patent/US6750214B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20030220332A1 (en)	2003-11-27
MA26414A1 (fr)	2004-12-20
HN1996000082A (es)	1997-06-30
AP9600900A0 (en)	1997-01-31
SK81698A3 (en)	2000-04-10
GB9526546D0 (en)	1996-02-28
ATE194598T1 (de)	2000-07-15
US6750214B2 (en)	2004-06-15
GR3034225T3 (en)	2000-12-29
NO982913L (no)	1998-07-30
ES2151192T3 (es)	2000-12-16
AU1371997A (en)	1997-07-17
WO1997023462A1 (en)	1997-07-03
AP715A (en)	1998-12-30
OA10703A (en)	2002-11-28
HUP9903560A3 (en)	2000-07-28
DE69609353D1 (de)	2000-08-17
YU68896A (sh)	1999-07-28
JPH11501668A (ja)	1999-02-09
US6642242B2 (en)	2003-11-04
EP0877734A1 (en)	1998-11-18
HRP960616A2 (en)	1998-06-30
DK0877734T3 (da)	2000-11-20
JP3070958B2 (ja)	2000-07-31
TNSN96161A1 (fr)	2005-03-15
EP0877734B1 (en)	2000-07-12
CA2236814A1 (en)	1997-07-03
ZA9610784B (en)	1998-06-22
PL327610A1 (en)	1998-12-21
CZ197698A3 (cs)	1999-03-17
TR199801195T2 (xx)	1998-10-21
NZ325248A (en)	1999-09-29
DE69609353T2 (de)	2000-12-07
CO4480106A1 (es)	1997-07-09
PT877734E (pt)	2000-12-29
AR005166A1 (es)	1999-04-14
US6103738A (en)	2000-08-15
BR9612263A (pt)	1999-07-13
KR19990076693A (ko)	1999-10-15
US20020049322A1 (en)	2002-04-25
BG102559A (en)	1999-03-31
CA2236814C (en)	2001-09-18
NO982913D0 (no)	1998-06-22
HUP9903560A2 (hu)	2000-05-28
AU708979B2 (en)	1999-08-19

Publication	Publication Date	Title
IS4731A (is)	1998-04-29	Kínólín og kínazólín efnasambönd nytsamleg í meðferð
KR960008976A (ko)	1996-03-22	처리장치 및 처리방법
DK0915880T3 (da)	2008-02-11	Azolotriaziner og pyrimidiner
FI970990A7 (fi)	1997-03-10	Syövän toteaminen ja hoito
ZA98166B (en)	1999-07-09	Quinoline and quinazoline compounds useful in therapy
DE69827915D1 (de)	2005-01-05	Verarbeitungsverfahren und -vorrichtung
FI963126L (fi)	1998-02-10	Stanoliseos ja sen käyttö
FI965161L (fi)	1997-02-13	Käyttäjän tunnistusmenetelmä ja laite
NO972236D0 (no)	1997-05-15	Dihydropyrimidiner og anvendelse derav
NO307513B1 (no)	2000-04-17	2,8-disubstituert chinazolinon og anvendelse derav
DE69831755D1 (de)	2006-02-09	Optoakustische kontrastmittel und anwendungsverfahren
DE69708619D1 (de)	2002-01-10	Elektroentionisierungsvorrichtung und methode
NO983576L (no)	1999-02-08	Br°nnbehandlingsfluider og fremgangsmÕter
DK0804078T3 (da)	2000-04-10	Sammensætning og anvendelse deraf
NO961346L (no)	1996-10-07	Benzonitriler og benzofluorider
NO980718D0 (no)	1998-02-20	Bicykliske 4-aralkylaminopyrimidinderivater og tyrosinkinaseinhibitorer
DE69736267D1 (de)	2006-08-17	Plasmabehandlungsvorrichtung und -verfahren
DE69628873D1 (de)	2003-08-07	Ausrichtgerät und -verfahren
NO984836L (no)	1998-12-16	Substituerte benzylaminer og deres anvendelse for behandling av depresjon
FI962103A0 (fi)	1996-05-17	Höyrystyslaite ja menetelmä
DE69620243D1 (de)	2002-05-02	Haupt- und nebenstromfilter
DE69737490D1 (de)	2007-05-03	Anzeigegerät und dessen Herstellungsverfahren
NO983556L (no)	1998-08-03	Formulering og anvendelse
NO992561D0 (no)	1999-05-27	Oppslemmingsbehandlingssystem og oppslemmingsbehandlingsmetode
KR960032614U (ko)	1996-10-24	탈자 및 자화기